Infected mice (Fig. 2C, group 19). When the mice were infected with

Infected mice (Fig. 2C, group 19). When the mice were infected with dbpAB and treated at six weeks, one out of four joints samples contained B. burgdorferi DNA. The bacterial load in this sample was lower than in the joint samples of dbpAB/ dbpAB infected and treated mice (Fig. 4, groups 19 and 20). IgG levels against the whole cell B.PLOS ONE | DOI:10.1371/journal.pone.CCX282-B cancer 0121512 March 27,12 /DbpA and B EPZ-5676 molecular weight Promote Arthritis and Post-Treatment Persistence in MiceTable 5. B. burgdorferi culture and PCR results of Experiment IV at 15 weeks of infection. Culture at 15 wk Group 16 17 18 19 20 ND Not determined doi:10.1371/journal.pone.0121512.t005 Strain/treatment Uninfected dbpAB/dbpAB dbpAB dbpAB/dbpAB + Cef6 dbpAB + Cef6 Ear 0/4 4/4 4/4 0/4 0/4 Bladder 0/4 4/4 4/4 0/4 0/4 Joint ND ND 4/4 0/4 0/4 Ear 0/4 4/4 4/4 0/4 0/4 OspA PCR Bladder 0/4 4/4 4/4 0/4 0/4 Joint 0/4 4/4 4/4 4/4 1/burgdorferi antigen, C6 peptide, DbpA or DbpB in the sera of mice infected with dbpAB/ dbpAB or with dbpAB were not affected by the ceftriaxone treatment at six week time point (Fig. 3B, S1D, E, F Fig., groups 17?0). In conclusion, the results demonstrate that borrelial DNA persist specifically in the joint tissue of mice infected with DbpA and B expressing B. burgdorferi also when the mice are treated at a later time point of infection.DiscussionIn the present study, we evaluated the role of DbpA and B adhesins in dissemination of LB, in the development of joint manifestations, and in bacterial persistence after ceftriaxone treatment in mice. The effect of immunosuppression by anti-TNF-alpha on the post-treatment progression of LB was evaluated. Specifically, immunosuppression was used to characterize the nature of the persisting material in antibiotic treated animals. The results show that, indeed, expression of both DbpA and B on B. burgdorferi is required for arthritis development. Also, post-treatment persistence of borrelial DNA in mouse joints was dependent on DbpA and B. Importantly, immunosuppression did not turn the joint tissue samples of the antibiotic treated animals to B. burgdorferi culture positive, thus suggesting that the persisting remnants in the joints of dbpAB/dbpAB infected mice is DNA or DNA containing structures rather than live bacteria. Mice were infected with previously characterized B. burgdorferi strains dbpAB and dbpAB/dbpAB [16]. The strains have been constructed in B. burgdorferi B31 5A13 background and are genetically identical except for the difference in the ability to express DbpA and B adhesins. The strains have the same plasmid content since both have lost plasmids cp9, lp5, lp21, lp28-4, lp25, and lp56 [16]. The positive C6 peptide antibody results (S1A and D Fig.) in most of dbpAB/dbpAB and dbpAB infected mice indicate that both strains retain the plasmid lp28-1 which is associated with an arthritic phenotype of B. burgdorferi [27]. Both strains are infectious in immunocompetent BALB/c mice, but the ID50 value of dbpAB is 104 times higher than the ID50 value of dbpAB/dbpAB. However, the use of 106 dbpAB bacteria to infect BALB/c mice leads to joint infection [16]. Because of this, the C3H/HeN mice in the present study were infected with 106 bacteria, which ensured that also dbpAB inoculated mice developed disseminated infection. Although Lyme arthritis is probably the most studied manifestation of LB, molecular mechanisms targeting B. burgdorferi to joint tissues and molecules responsible for the induction of arthritis are poorl.Infected mice (Fig. 2C, group 19). When the mice were infected with dbpAB and treated at six weeks, one out of four joints samples contained B. burgdorferi DNA. The bacterial load in this sample was lower than in the joint samples of dbpAB/ dbpAB infected and treated mice (Fig. 4, groups 19 and 20). IgG levels against the whole cell B.PLOS ONE | DOI:10.1371/journal.pone.0121512 March 27,12 /DbpA and B Promote Arthritis and Post-Treatment Persistence in MiceTable 5. B. burgdorferi culture and PCR results of Experiment IV at 15 weeks of infection. Culture at 15 wk Group 16 17 18 19 20 ND Not determined doi:10.1371/journal.pone.0121512.t005 Strain/treatment Uninfected dbpAB/dbpAB dbpAB dbpAB/dbpAB + Cef6 dbpAB + Cef6 Ear 0/4 4/4 4/4 0/4 0/4 Bladder 0/4 4/4 4/4 0/4 0/4 Joint ND ND 4/4 0/4 0/4 Ear 0/4 4/4 4/4 0/4 0/4 OspA PCR Bladder 0/4 4/4 4/4 0/4 0/4 Joint 0/4 4/4 4/4 4/4 1/burgdorferi antigen, C6 peptide, DbpA or DbpB in the sera of mice infected with dbpAB/ dbpAB or with dbpAB were not affected by the ceftriaxone treatment at six week time point (Fig. 3B, S1D, E, F Fig., groups 17?0). In conclusion, the results demonstrate that borrelial DNA persist specifically in the joint tissue of mice infected with DbpA and B expressing B. burgdorferi also when the mice are treated at a later time point of infection.DiscussionIn the present study, we evaluated the role of DbpA and B adhesins in dissemination of LB, in the development of joint manifestations, and in bacterial persistence after ceftriaxone treatment in mice. The effect of immunosuppression by anti-TNF-alpha on the post-treatment progression of LB was evaluated. Specifically, immunosuppression was used to characterize the nature of the persisting material in antibiotic treated animals. The results show that, indeed, expression of both DbpA and B on B. burgdorferi is required for arthritis development. Also, post-treatment persistence of borrelial DNA in mouse joints was dependent on DbpA and B. Importantly, immunosuppression did not turn the joint tissue samples of the antibiotic treated animals to B. burgdorferi culture positive, thus suggesting that the persisting remnants in the joints of dbpAB/dbpAB infected mice is DNA or DNA containing structures rather than live bacteria. Mice were infected with previously characterized B. burgdorferi strains dbpAB and dbpAB/dbpAB [16]. The strains have been constructed in B. burgdorferi B31 5A13 background and are genetically identical except for the difference in the ability to express DbpA and B adhesins. The strains have the same plasmid content since both have lost plasmids cp9, lp5, lp21, lp28-4, lp25, and lp56 [16]. The positive C6 peptide antibody results (S1A and D Fig.) in most of dbpAB/dbpAB and dbpAB infected mice indicate that both strains retain the plasmid lp28-1 which is associated with an arthritic phenotype of B. burgdorferi [27]. Both strains are infectious in immunocompetent BALB/c mice, but the ID50 value of dbpAB is 104 times higher than the ID50 value of dbpAB/dbpAB. However, the use of 106 dbpAB bacteria to infect BALB/c mice leads to joint infection [16]. Because of this, the C3H/HeN mice in the present study were infected with 106 bacteria, which ensured that also dbpAB inoculated mice developed disseminated infection. Although Lyme arthritis is probably the most studied manifestation of LB, molecular mechanisms targeting B. burgdorferi to joint tissues and molecules responsible for the induction of arthritis are poorl.